Table of Contents

Clinical Studies

• Open Access

  Retrospective Analysis of Treatment Pathways in Patients With BRAF^V600E-mutant Metastatic Colorectal Carcinoma – MORSE^CRC

  ARMIN GERGER, WOLFGANG EISTERER, STEFAN FUXIUS, SARA BASTIAN, DIETER KOEBERLE, MANFRED WELSLAU, DILARA AKHOUNDOVA SANOYAN, CHRISTIAN MAAS, JENS UHLIG, KLAUS FENCHEL, RICHARD GREIL, EYCK VON DER HEYDE, GAËLLE RHYNER AGOCS, RUDOLF WEIDE, MONIKA SCHWAGER, FRANK REICHENBACH, DOMINIK PAUL MODEST and RALPH FRITSCH

  Anticancer Research October 2022, 42 (10) 4773-4785; DOI: https://doi.org/10.21873/anticanres.15982
• Open Access

  Surgical Administration of Indocyanine Green in Hepatectomy for Improved Bile Leakage Detection

  TAKEHIKO HANAKI, KEISUKE GOTO, MASAKI MORIMOTO, YUKI MURAKAMI, TOMOYUKI MATSUNAGA, MANABU YAMAMOTO, NARUO TOKUYASU, TERUHISA SAKAMOTO, TOSHIMICHI HASEGAWA and YOSHIYUKI FUJIWARA

  Anticancer Research October 2022, 42 (10) 4787-4793; DOI: https://doi.org/10.21873/anticanres.15983
• You have access

  Long-term Local Control and Overall Survival After Radiotherapy in Oligoprogressive Patients During Treatment With Checkpoint Inhibitors

  PIM J.J. DAMEN, KARIJN P.M. SUIJKERBUIJK, ANNE S.R. VAN LINDERT, WIETSE S.C. EPPINGA, SHERIF Y. EL SHAROUNI and JOOST J.C. VERHOEFF

  Anticancer Research October 2022, 42 (10) 4795-4804; DOI: https://doi.org/10.21873/anticanres.15984
• You have access

  Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain Radiotherapy

  YUSUKE TAKAYAMA, JUN YANO, REN SEIKE, SHOHEI MISHIMA and HIROYASU SHODA

  Anticancer Research October 2022, 42 (10) 4805-4812; DOI: https://doi.org/10.21873/anticanres.15985
• Open Access

  Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor

  HIROMI OZAWA, TOMOKO HIGUCHI, YUKIE FUJIMOTO, AYAKO BUN, REIKO FUKUI, HARUKA KANAOKA, MASAYUKI NAGAHASHI, KAZUHIRO KITAJIMA, KOICHIRO YAMAKADO and YASUO MIYOSHI

  Anticancer Research October 2022, 42 (10) 4813-4824; DOI: https://doi.org/10.21873/anticanres.15986
• You have access

  Tumor Load Matters – the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian Cancer

  EVA EGGER, FREYA MERKER, DAMIAN J. RALSER, MATEJA CONDIC, MILKA MARINOVA, MICHAEL MUDERS, MATTHIAS STOPE and ALEXANDER MUSTEA

  Anticancer Research October 2022, 42 (10) 4825-4831; DOI: https://doi.org/10.21873/anticanres.15987
• You have access

  Outcomes and Side Effects of Preoperative Chemoradiotherapy for Locally Advanced Upper Rectal Cancer

  SANDRA CHOMICKI, SOPHIE CHAPET, MOUSSATA DRIFA, MEHDI OUAISSI, PASCAL BOURLIER, KAMEL DEBBI, GOKOULAKRICHENANE LOGANADANE and GILLES CALAIS

  Anticancer Research October 2022, 42 (10) 4833-4840; DOI: https://doi.org/10.21873/anticanres.15988
• You have access

  Relationship Between Fat Mass Indices and Postoperative Complications After Laparoscopic Gastrectomy in Patients With Gastric Cancer: A Propensity Score Matching Analysis

  RYOTA MATSUI, NORIYUKI INAKI, TOSHIKATSU TSUJI and TETSU FUKUNAGA

  Anticancer Research October 2022, 42 (10) 4841-4848; DOI: https://doi.org/10.21873/anticanres.15989
• You have access

  Intraoperative Holographic Guidance Using Virtual Reality and Mixed Reality Technology During Laparoscopic Colorectal Cancer Surgery

  SHUNJIN RYU, TAKAHIRO KITAGAWA, KEISUKE GOTO, ATSUKO OKAMOTO, RUI MARUKUCHI, KEIGO HARA, RYUSUKE ITO and YUKIO NAKABAYASHI

  Anticancer Research October 2022, 42 (10) 4849-4856; DOI: https://doi.org/10.21873/anticanres.15990
• You have access

  Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective Study

  JIAN-RI LI, SHIAN-SHIANG WANG, CHUAN-SHU CHEN, CHENG-KUANG YANG, KEVIN LU, CHEN-LI CHENG, SHENG-CHUN HUNG, SHU-YEN CHEN, CHIANN YI HSU and KUN-YUAN CHIU

  Anticancer Research October 2022, 42 (10) 4857-4866; DOI: https://doi.org/10.21873/anticanres.15991
• You have access

  Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors

  HARUKA KANAOKA, MASAYUKI NAGAHASHI, YUSA ATAKE, AKIRA HATTORI, AYAKO BUN, REIKO FUKUI, HIROMI OZAWA, YUKIE FUJIMOTO, TOMOKO HIGUCHI, KEIKO NATORI, MICHIKO IMAMURA, KEIKO MURASE, YUICHI TAKATSUKA and YASUO MIYOSHI

  Anticancer Research October 2022, 42 (10) 4867-4878; DOI: https://doi.org/10.21873/anticanres.15992
• You have access

  Simultaneous Detection and HER2 Profiling of Circulating Breast Cancer Cells in Clinical Patients Using a Rare Cell Sorter

  TOMOKO MORI, ATSUKO FURUKAWA, TURAN BILAL, AYA UEDA, HIROKO BANDO, TAISUKE MASUDA, FUMIHITO ARAI and SATOSHI MATSUSAKA

  Anticancer Research October 2022, 42 (10) 4879-4886; DOI: https://doi.org/10.21873/anticanres.15993
• You have access

  Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy

  SHINYU KISE, YOSHIHISA ARAKAKI, WATARU KUDAKA, TAKURO ARIGA, NAGISA KINJO, HIROSHI KOHATU and YOICHI AOKI

  Anticancer Research October 2022, 42 (10) 4887-4893; DOI: https://doi.org/10.21873/anticanres.15994
• You have access

  Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib

  YUKI FUJIMOTO, TADASHI NAMISAKI, SOICHI TAKEDA, KOJI MURATA, MASAHIDE ENOMOTO, HIROAKI TAKAYA, YUKI TSUJI, YUKIHISA FUJINAGA, YASUHIKO SAWADA, NORIHISA NISHIMURA, KOH KITAGAWA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, KEI MORIYA, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI

  Anticancer Research October 2022, 42 (10) 4895-4905; DOI: https://doi.org/10.21873/anticanres.15995
• You have access

  Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

  TAKURO OKADA, TAKASHI MATSUKI, CHIHIRO FUSHIMI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KUNIHIKO TOKASHIKI, TATSUYA ITO, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, KENJI HANYU, GO OMURA, HIDEKI TAKAHASHI, TAKU YAMASHITA, NOBUHIKO ORIDATE and KIYOAKI TSUKAHARA

  Anticancer Research October 2022, 42 (10) 4907-4912; DOI: https://doi.org/10.21873/anticanres.15996
• You have access

  Awake Breast Conservative Surgery: A Strategy to Shorten Surgical Waiting Lists During and Post COVID-19 Emergency

  GIANLUCA VANNI, MARCO PELLICCIARO, MARCO MATERAZZO, JONATHAN CASPI, MARCELLO CHIOCCHI, FEDERICO TACCONI, ANNALISA NOCE, GIANLUCA NICOLAI, ILARIA PORTARENA, CHIARA BUONOMO, DAURI MARIO and ORESTE CLAUDIO BUONOMO

  Anticancer Research October 2022, 42 (10) 4913-4919; DOI: https://doi.org/10.21873/anticanres.15997
• You have access

  Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung Cancer

  YOHEI MATSUI, TADAAKI YAMADA, KENJI MORIMOTO, YUKI KATAYAMA, OSAMU HIRANUMA, SHINSUKE SHIOTSU, NOBUYO TAMIYA, TAKAYUKI TAKEDA, YOSHIE MORIMOTO, MASAHIRO IWASAKU, SHINSAKU TOKUDA and KOICHI TAKAYAMA

  Anticancer Research October 2022, 42 (10) 4921-4928; DOI: https://doi.org/10.21873/anticanres.15998
• You have access

  Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) for Patients With Potentially Resectable Esophageal Cancer

  MAKOTO SAKAI, MAKOTO SOHDA, SHINTARO UCHIDA, ARISA YAMAGUCHI, TAKAYOSHI WATANABE, HIDEYUKI SAITO, YASUNARI UBUKATA, NOBUHIRO NAKAZAWA, KENGO KURIYAMA, AKIHIKO SANO, HIROOMI OGAWA, TAKEHIKO YOKOBORI, SHIN-EI NODA, TATSUYA OHNO, KEN SHIRABE and HIROSHI SAEKI

  Anticancer Research October 2022, 42 (10) 4929-4935; DOI: https://doi.org/10.21873/anticanres.15999
• You have access

  Comparison of Survival Outcomes Based on Pre-treatment Pleural Effusion in Advanced Epithelial Ovarian Cancer

  JUHUN LEE and DAE GY HONG

  Anticancer Research October 2022, 42 (10) 4937-4943; DOI: https://doi.org/10.21873/anticanres.16000
• You have access

  Prognostic Significance of Clinical Factors Including BRCA Mutation in Epithelial Ovarian, Peritoneal, Fallopian Tube Cancer

  JI YOUNG KIM, HAEIL PARK, DAE WOO LEE, MIN JEONG KIM, JAE EUN SHIN, KYUNG EUN LEE and HAE NAM LEE

  Anticancer Research October 2022, 42 (10) 4945-4954; DOI: https://doi.org/10.21873/anticanres.16001
• You have access

  Clinicopathological Characteristics of Advanced Epstein–Barr Virus-associated Gastric Cancer Highlighting Aberrant p53 Expression

  HYEONGUK JANG, AN NA SEO and MOONSIK KIM

  Anticancer Research October 2022, 42 (10) 4955-4962; DOI: https://doi.org/10.21873/anticanres.16002
• You have access

  Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study

  MASASHI UTSUMI, MASARU INAGAKI, KOJI KITADA, NAOYUKI TOKUNAGA, MIDORI KONDO, KOSUKE YUNOKI, YUYA SAKURAI, RYOSUKE HAMANO, HIDEAKI MIYASOU, YOUSUKE TSUNEMITSU and SHINYA OTSUKA

  Anticancer Research October 2022, 42 (10) 4963-4971; DOI: https://doi.org/10.21873/anticanres.16003
• You have access

  The Effect and Tolerability of Second-line Chemotherapy Are Associated With Disease Control by Nivolumab Chemotherapy in Patients With Gastric Cancer

  HIROSHI MATSUOKA, TOMOHIRO MIZUNO, MINAMI SAKAI, KAZUMITSU SUZUKI, AKIKO SERIZAWA, MASAYA NAKAUCHI, TSUYOSHI TANAKA, SUSUMU SHIBASAKI, TAKAHIRO HAYASHI and KOICHI SUDA

  Anticancer Research October 2022, 42 (10) 4973-4980; DOI: https://doi.org/10.21873/anticanres.16004
• You have access

  Efficacy and Safety of Radium-223 for Castration-resistant Prostate Cancer With Bone Metastasis Before and After Docetaxel

  KO OKABE, NAOKI TERADA, TATSUYA SHIRAKAWA, CHIE ONIZUKA, TOMOYA KIMURA, YASUHIRO YAMASHITA, ISAMU OTUKA, TAKASHI UENO, MASAFUMI NAGANO, HIROKI TAKAMORI, SHOICHIRO MUKAI and TOSHIYUKI KAMOTO

  Anticancer Research October 2022, 42 (10) 4981-4987; DOI: https://doi.org/10.21873/anticanres.16005
• You have access

  Combined Inflammation and Nutrition Factors Reinforce the Prognostic Prediction for Stage III Colorectal Cancer Patients

  SHINYA KATO, NORIKATSU MIYOSHI, SHIKI FUJINO, SOICHIRO MINAMI, CHU MATSUDA, MASAYOSHI YASUI, MASAYUKI OHUE, YUKI SEKIDO, TSUYOSHI HATA, TAKAYUKI OGINO, HIDEKAZU TAKAHASHI, MAMORU UEMURA, HIROFUMI YAMAMOTO, YUICHIRO DOKI and HIDETOSHI EGUCHI

  Anticancer Research October 2022, 42 (10) 4989-4999; DOI: https://doi.org/10.21873/anticanres.16006
• You have access

  Long-term Outcomes and Prognostic Factors of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma

  KAZUYOSHI NAGATA, RYU SASAKI, SHINICHI IWATSU, MASANORI FUKUSHIMA, MASAFUMI HARAGUCHI, SHINOBU YAMAMICHI, SATOSHI MIUMA, HISAMITSU MIYAAKI, NAOTA TAURA, TAKUYA YAMAZAKI and KAZUHIKO NAKAO

  Anticancer Research October 2022, 42 (10) 5001-5007; DOI: https://doi.org/10.21873/anticanres.16007